Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT04815720

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +12 more
Locations
  • Highlands Oncology Group, PA - North Hills Springdale, Arkansas, United States
  • California Cancer Associates for Research and Excellence (CCARE)-Fresno Fresno, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 15 locations
View Trial Details
Completed

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

NCT02573493

Conditions
Cancer of Head and Neck, Cancer of the Head and Neck, Carcinoma, +11 more
Locations
  • The University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Sanford Cancer Center Sioux Falls, South Dakota, United States
View Trial Details
Completed

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

NCT03997968

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
View all 16 locations
View Trial Details
Completed

A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors

NCT03518554

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +40 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions